2020 ALT/SGPT Test Volume and Sales Forecasts: US, Europe, Japan-Hospitals, Commercial Labs, POC Locations
This new report from VPGMarketResearch provides analysis of ALT/SGPT testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
Geographic Coverage
France, Germany, Italy, Japan, Spain, UK, USA
Market Segmentation
Centralized Testing
Geographic Coverage
France, Germany, Italy, Japan, Spain, UK, USA
Market Segmentation
Centralized Testing
- Hospitals
- Commercial/Private Laboratories
- Physician Offices/Group Practices
- Ambulatory Care Centers
- Cancer Clinics
- Surgery Centers
TEST ANALYSIS
Clinical significance, current diagnostic procedures, and emerging tests
GEOGRAPHIC COVERAGE
France, Germany, Italy, Japan, Spain, UK, USA
MARKET SEGMENTATION
CENTRALIZED TESTING
Hospitals
Commercial/Private Laboratories
POC/DECENTRALIZED TESTING
Clinical significance, current diagnostic procedures, and emerging tests
GEOGRAPHIC COVERAGE
France, Germany, Italy, Japan, Spain, UK, USA
MARKET SEGMENTATION
CENTRALIZED TESTING
Hospitals
Commercial/Private Laboratories
POC/DECENTRALIZED TESTING
LIST OF TABLES
France: Test Volume and Diagnostics Sales Forecasts By Market Segment
Germany: Test Volume and Diagnostics Sales Forecasts By Market Segment
Italy: Test Volume and Diagnostics Sales Forecasts By Market Segment
Japan: Test Volume and Diagnostics Sales Forecasts By Market Segment
Spain: Test Volume and Diagnostics Sales Forecasts By Market Segment
UK: Test Volume and Diagnostics Sales Forecasts By Market Segment
USA: Test Volume and Diagnostics Sales Forecasts By Market Segment
France: Test Volume and Diagnostics Sales Forecasts By Market Segment
Germany: Test Volume and Diagnostics Sales Forecasts By Market Segment
Italy: Test Volume and Diagnostics Sales Forecasts By Market Segment
Japan: Test Volume and Diagnostics Sales Forecasts By Market Segment
Spain: Test Volume and Diagnostics Sales Forecasts By Market Segment
UK: Test Volume and Diagnostics Sales Forecasts By Market Segment
USA: Test Volume and Diagnostics Sales Forecasts By Market Segment
More Publications
2017 Enteric Diseases: Supplier Shares and Sales Segment Forcasts by Country--Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--France, Germany, Italy, Japan, Spain, UK, US
US$ 11,500.00
August 2017
389 pages
Emerging Tumor Markers, Country Market Shares, Strategic Profiles of Leading Reagent and Instrument Suppliers, 2019
US$ 3,850.00
July 2019
286 pages
2018-2022 Antithrombin III: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
US$ 4,350.00
January 2018
197 pages
2017-2021 Syphilis Diagnostic Testing Market
US$ 3,915.00
February 2017
231 pages
2016-2020 Emerging Opportunities in the Japanese HIV/AIDS Diagnostics Testing Market
US$ 1,840.00
March 2016
250 pages
